When considering alteplase for the treatment of acute ischemic stroke, do not use it in patients with the following conditions:

- Intracranial hemorrhage

- Subarachnoid hemorrhage

- Internal bleeding

- Stroke within the last three months

- Intracranial or intraspinal surgery within the last three months

- Serious head trauma within the last three months

- Intracranial neoplasms, arteriovenous malformations, or aneurysms

- Conditions that increase the risk of bleeding

- Currently severe uncontrolled hypertension

Alteplase is FDA pregnancy category C. Research has not shown whether it crosses the placenta or gets excreted in human milk. It has not had much research in pregnant women, nursing mothers, or pediatric patients.